IMUC is cutting edge. Immunotherapy is very powerful monoclonals got gobbled
Up by big companies. Imuc is the next level of immunotherapy. I would be very surprised if this does not hit 50 within 18 months. Bull markets lift all stocks and we are going to have a bull market. History shows 2nd term presidents always have huge bull market. This will look like 1999 biotech run all over again.
IMUC GALE GNBT.OB all very promising technology. I pick biotechs based on technological platforms. The monoclonal platforms were bought out. The antigen dendritic pulse platform is brilliant
I expect IMUC and GALE to be super successful and probably bought. But they will be at 2 billion marketcap by that time. So do the math and figure out what the price will be!!!
A couple of things. Firstly, in my portfolio, I find almost a reverse effect with my speculative positions (almost all biotechs) and larger caps in a bull mkt. Lots of people, including myself, will shift to larger caps and ETF's for more guaranteed, if smaller, immediate gains in a decidedly bull run.
Second, I don't see much possibility for $50 or even half that before the end of PII - unless there is an early approval. I'm sure it might've happened but in over 15 years I've never seen a co. bought out before the end of PII while not having an income stream already in place, and then only rarely. INHX is the only one that comes immediately to mind. After all, the overall stats are pretty stark. the chances of any biotech going from P1 to PII or PII to PIII are in 30's% range and even PIII to market is well under 50%.
Anyone here taken a look at SNTI? I've traded this Co. for over 3yrs now but not currently holding. They are at least unique in their path to today - from agtech to biotech. And they do already have a revenue stream. I'd be interested in what others might have to say...